keyword
https://read.qxmd.com/read/38578397/sglt2-inhibitors%C3%A2-the-new-standard-of-care-for-cardiovascular-renal-and-metabolic-protection-in-type-2-diabetes-a-narrative-review
#21
REVIEW
Samuel Seidu, Vicki Alabraba, Sarah Davies, Philip Newland-Jones, Kevin Fernando, Stephen C Bain, Jane Diggle, Marc Evans, June James, Naresh Kanumilli, Nicola Milne, Adie Viljoen, David C Wheeler, John P H Wilding
A substantial evidence base supports the use of sodium-glucose cotransporter-2 inhibitors (SGLT2is) in the treatment of type 2 diabetes mellitus (T2DM). This class of medicines has demonstrated important benefits that extend beyond glucose-lowering efficacy to protective mechanisms capable of slowing or preventing the onset of long-term cardiovascular, renal and metabolic (CVRM) complications, making their use highly applicable for organ protection and the maintenance of long-term health outcomes. SGLT2is have shown cost-effectiveness in T2DM management and economic savings over other glucose-lowering therapies due to reduced incidence of cardiovascular and renal events...
April 5, 2024: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders
https://read.qxmd.com/read/38576408/administration-of-teclistamab-in-four-patients-with-multiple-myeloma-requiring-hemodialysis
#22
JOURNAL ARTICLE
Christy J Khouderchah, Madeleine Ochs, Matthew Pianko, Zahra Mahmoudjafari, Jordan Snyder, Iman Ahmed, Erica Campagnaro, Victoria R Nachar
OBJECTIVE: Relapsed/refractory multiple myeloma (MM) has poor outcomes, especially in heavily pretreated patients. Limited data exists on the use of novel therapies in MM patients with renal dysfunction. This case series describes the successful initiation of teclistamab in four patients with heavily pre-treated MM on hemodialysis (HD). DATA SOURCES: The medical records of four adult MM patients on HD who received teclistamab were retrospectively reviewed. DATA SUMMARY: All patients completed teclistamab step-up dosing and received at least one full dose...
April 5, 2024: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/38573465/specific-and-non-specific-aspects-and-future-challenges-of-icu-care-among-covid-19-patients-with-obesity-a-narrative-review
#23
REVIEW
Alexandra Beurton, Emma J Kooistra, Audrey De Jong, Helmut Schiffl, Mercedes Jourdain, Bruno Garcia, Damien Vimpère, Samir Jaber, Peter Pickkers, Laurent Papazian
PURPOSE OF REVIEW: Since the end of 2019, the coronavirus disease 2019 (COVID-19) pandemic has infected nearly 800 million people and caused almost seven million deaths. Obesity was quickly identified as a risk factor for severe COVID-19, ICU admission, acute respiratory distress syndrome, organ support including mechanical ventilation and prolonged length of stay. The relationship among obesity; COVID-19; and respiratory, thrombotic, and renal complications upon admission to the ICU is unclear...
April 4, 2024: Current Obesity Reports
https://read.qxmd.com/read/38571837/the-silent-victims-how-the-israel-palestine-war-impacts-the-management-of-chronic-kidney-disease-and-end-stage-renal-disease-patients
#24
EDITORIAL
Abhi C Lohana, Amit Gulati, Jatender Kumar, Fnu Shivani, Danesh Kumar
This article discusses the multifaceted impact of wars and armed conflicts on healthcare systems, with a focus on the Israel-Palestine war and its consequences for individuals with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The war has severely disrupted healthcare infrastructure, leading to damage or destruction of hospitals and clinics, shortages in medical supplies and staff, and interruptions in the delivery of essential services. This disruption poses significant challenges for the management of chronic conditions such as CKD and ESRD, where patients rely on regular and specialized care...
March 2024: Curēus
https://read.qxmd.com/read/38570744/impact-of-recipient-and-donor-pretransplantation-body-mass-index-on-early-postosperative-complications-after-lung-transplantation
#25
JOURNAL ARTICLE
E Atchade, C De Tymowski, E Lepitre, N Zappella, A Snauwaert, S Jean-Baptiste, A Tran-Dinh, B Lortat-Jacob, J Messika, H Mal, P Mordant, Y Castier, S Tanaka, P Montravers
BACKGROUND: Prior studies have assessed the impact of the pretransplantation recipient body mass index (BMI) on patient outcomes after lung transplantation (LT), but they have not specifically addressed early postoperative complications. Moreover, the impact of donor BMI on these complications has not been evaluated. The first aim of this study was to assess complications during hospitalization in the ICU after LT according to donor and recipient pretransplantation BMI. METHODS: All the recipients who underwent LT at Bichat Claude Bernard Hospital, Paris, between January 2016 and August 2022 were included in this observational retrospective monocentric study...
April 3, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38570631/chronic-kidney-disease-and-the-global-public-health-agenda-an-international-consensus
#26
REVIEW
Anna Francis, Meera N Harhay, Albert C M Ong, Sri Lekha Tummalapalli, Alberto Ortiz, Agnes B Fogo, Danilo Fliser, Prabir Roy-Chaudhury, Monica Fontana, Masaomi Nangaku, Christoph Wanner, Charu Malik, Anne Hradsky, Dwomoa Adu, Sunita Bavanandan, Ana Cusumano, Laura Sola, Ifeoma Ulasi, Vivekanand Jha
Early detection is a key strategy to prevent kidney disease, its progression and related complications, but numerous studies show that awareness of kidney disease at the population level is low. Therefore, increasing knowledge and implementing sustainable solutions for early detection of kidney disease are public health priorities. Economic and epidemiological data underscore why kidney disease should be placed on the global public health agenda - kidney disease prevalence is increasing globally and it is now the seventh leading risk factor for mortality worldwide...
April 3, 2024: Nature Reviews. Nephrology
https://read.qxmd.com/read/38565098/prognosis-of-iga-nephropathy-with-stage-3b-5-ckd
#27
JOURNAL ARTICLE
Zhanfei Wu, Hongfen Li, Youxia Liu, Fanghao Wang, Yue Xing, Wenying Li, Junya Jia, Tiekun Yan
Objective To investigate whether immunosuppressive therapy is beneficial in IgA nephropathy (IgAN) patients with eGFR < 45ml/min/1.73m2. Methods This retrospective study involved 110 IgAN patients for whom clinical data was available; of these, 90 had complete follow-up data. Patients were grouped based on whether they received immunotherapy during follow-up, their renal function, proteinuria levels, and the percentage of crescentic glomeruli observed at the time of renal biopsy. Results The mean eGFR for the participants was 32...
April 2, 2024: Kidney & Blood Pressure Research
https://read.qxmd.com/read/38562132/fetal-wilm-s-tumor-detection-preceding-the-development-of-isolated-lateralized-overgrowth-of-the-limb-a-case-report-and-review-of-literature
#28
Elie Bechara, Chloé Saadé, Caroline Geagea, Daniel Charouf, Pauline Abou Jaoude
Fetal Wilms tumor (WT) is extremely rare, but with advances in fetal imaging, more cases are being reported. The management of these cases remains challenging. Herein, we present the case of a full-term female infant diagnosed antenatally at 32 weeks of gestation with a right solid renal mass detected on routine prenatal ultrasound without polyhydramnios. At birth, the infant was healthy, with no evidence of dysmorphic features or abnormal laboratory tests to suggest a predisposition syndrome. Her family history was also unremarkable...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38561279/-guideline-for-the-diagnosis-and-management-of-multiple-myeloma-related-renal-impairment-2024-version
#29
JOURNAL ARTICLE
(no author information available yet)
Renal impairment is a common complication of multiple myeloma (MM). All patients with MM should be assessed for the presence and severity of renal impairment. The clinicopathological manifestations of MM-related renal impairment are diverse and complex; accordingly, except for light-chain nephropathy, which can often be diagnosed without biopsy based solely on clinical criteria, a renal biopsy is needed for an accurate diagnosis. Supportive care, such as adequate hydration, is required for all patients with MM-related renal impairment...
April 1, 2024: Zhonghua Nei Ke za Zhi [Chinese Journal of Internal Medicine]
https://read.qxmd.com/read/38560744/adaptation-of-the-serious-illness-conversation-guide-to-singapore-s-multicultural-setting-for-patients-with-heart-failure-renal-failure-or-cancer
#30
JOURNAL ARTICLE
Anna So Youn Lee, Swee Noi Tang, Gillian Li Gek Phua, Alethea Chung-Pheng Yee, Shirlyn Hui-Shan Neo
BACKGROUND: The Serious Illness Conversation Guide (SICG) was developed by Ariadne Labs in the United States. However, there is a scarcity of literature on the cross-cultural adaptations of the SICG in Asian settings. OBJECTIVES: We aimed to adapt the SICG for English-speaking patients with serious illnesses in Singapore. METHODS: We purposively recruited 28 patients with advanced stages of heart failure, renal failure, or cancer from a tertiary hospital...
2024: Palliative medicine reports
https://read.qxmd.com/read/38560354/ceftriaxone-induced-severe-hemolytic-anemia-renal-calculi-and-cholecystolithiasis-in-a-3-year-old-child-a-case-report-and-literature-review
#31
Enfu Tao, Huangjia Zhou, Meili Zheng, Yisha Zhao, Junfen Zhou, Junhui Yuan, Tianming Yuan, Changhua Zheng
Ceftriaxone is widely used in pediatric outpatient care for its efficacy against respiratory and digestive system infections, yet its increasing association with severe immune hemolytic reactions requires heightened vigilance from pediatricians. This report details a rare and severe case of ceftriaxone-induced severe immune hemolytic anemia (IHA), hemolytic crisis, myocardial injury, liver injury, renal calculi, and cholecystolithiasis in a previously healthy 3-year-old child. The child, treated for bronchitis, experienced sudden pallor, limb stiffness, and altered consciousness following the fifth day of ceftriaxone infusion, with hemoglobin (Hb) levels precipitously dropping to 21 g/L...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38558727/severe-sinus-dysfunction-in-the-context-of-chronic-lithium-intoxication-and-poorly-controlled-hypothyroidism
#32
Carlos M Ardila, Alejandro López-Valencia, Daniel González-Arroyave
Cardiotoxicity associated with lithium is not a common event; however, it is potentially life-threatening, manifesting electrocardiographically with sinoatrial blocks, high-degree atrioventricular blocks, QT prolongation, and ventricular tachyarrhythmias. This case report presents a patient with severe sinus dysfunction in a clinically severe presentation secondary to cardiogenic shock. The patient sought medical attention for a one-week history of non-anginal chest pain, dizziness without syncope, generalized weakness, and somnolence progressing to bedridden status in the days preceding hospital admission...
February 2024: Curēus
https://read.qxmd.com/read/38558462/bone-marrow-transplantation-and-bone-marrow-derived-mesenchymal-stem-cell-therapy-in-epidermolysis-bullosa-a-systematic-review
#33
REVIEW
Maulidina Agustin, Anita Mahadewi, Retno Danarti
Epidermolysis bullosa (EB) is a genodermatosis that lacks effective treatments and requires supportive care for its severe, life-threatening manifestations. Bone marrow transplantation (BMT) and its derived cells have been suggested to improve clinical symptoms and quality of life. A comprehensive search was conducted for publications evaluating BMT and bone marrow-derived mesenchymal stem cell (BM-MSC) therapy for EB in PubMed/MEDLINE, Google Scholar, and Cochrane databases from inception until June 2023. A total of 55 participants with severe forms of EB had BMT and/or BM-MSCs, with recessive dystrophic EB as the most common EB type; 53 (96...
April 1, 2024: Pediatric Dermatology
https://read.qxmd.com/read/38552059/multiorgan-failure-caused-by-pembrolizumab-and-axitinib-in-a-woman-affected-by-metastatic-clear-cell-renal-cell-carcinoma-a-case-report-and-literature-review
#34
JOURNAL ARTICLE
Andrea Di Marco, Grazia Artioli, Adolfo Favaretto, Nicolò Cavasin, Umberto Basso
RATIONALE: Treatment with a combination of immune checkpoint inhibitors (ICIs) (pembrolizumab or nivolumab) and oral Tyrosine Kinase Inhibitors (TKI) targeting angiogenesis (axitinib, cabozantinib or lenvatinib) has shown benefits in terms of efficacy and survival in metastatic renal cell carcinoma (mRCC), with a favorable toxicity profile. However, some rare and serious treatment-related adverse events can be difficult to manage. PATIENT CONCERNS: Here we report the first case of an mRCC patient who, after only 2 administrations of pembrolizumab-axitinib, experienced severe multiorgan failure (MOF) with heart failure, oliguria and acute hepatitis requiring aggressive supportive treatment in intensive care unit...
March 29, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38551363/triage-of-v-v-ecmo-referrals-for-covid-19-respiratory-failure
#35
JOURNAL ARTICLE
Erin Niles, Daniel J Haase, Quincy Tran, James A Gerding, Emily Esposito, Siamak Dahi, Samuel M Galvagno, Kimberly Boswell, Raymond Rector, Robert Pearce, Maie Abdel-Wahab, Aditi Singh, Saad Pirzada, Ali Tabatabai, Elizabeth K Powell
BACKGROUND: As the pandemic progressed, the use of extracorporeal membrane oxygenation (ECMO) for COVID-19-related acute respiratory distress syndrome increased, and patient triage and transfer to ECMO centers became important to optimize patient outcomes. Our objectives are to identify predictors of patient transfer for veno-venous extracorporeal membrane oxygenation (V-V ECMO) evaluation as well as to describe the outcomes of accepted patients. METHODS: This is a single-center, retrospective analysis of V-V ECMO transfer requests for adult patients with known or suspected COVID-19 and respiratory failure from March 2020 until March 2021...
March 29, 2024: Artificial Organs
https://read.qxmd.com/read/38546287/survival-of-critically-ill-covid-19-patients-in-sweden-during-the-first-two-and-a-half-years-of-the-pandemic
#36
JOURNAL ARTICLE
Ailiana Santosa, Jonatan Oras, Huiqi Li, Chioma Nwaru, Brian Kirui, Fredrik Nyberg
OBJECTIVES: Some studies have examined survival trends among critically ill COVID-19 patients, but most were case reports, small cohorts, and had relatively short follow-up periods. We aimed to examine the survival trend among critically ill COVID-19 patients during the first two and a half years of the pandemic and investigate potential predictors across different variants of concern periods. DESIGN: Prospective cohort study. SETTING: Swedish ICUs, between March 6, 2020, and December 31, 2022...
March 28, 2024: Critical Care Medicine
https://read.qxmd.com/read/38540976/personalized-medicine-transformed-chatgpt-s-contribution-to-continuous-renal-replacement-therapy-alarm-management-in-intensive-care-units
#37
JOURNAL ARTICLE
Mohammad S Sheikh, Charat Thongprayoon, Fawad Qureshi, Supawadee Suppadungsuk, Kianoush B Kashani, Jing Miao, Iasmina M Craici, Wisit Cheungpasitporn
The accurate interpretation of CRRT machine alarms is crucial in the intensive care setting. ChatGPT, with its advanced natural language processing capabilities, has emerged as a tool that is evolving and advancing in its ability to assist with healthcare information. This study is designed to evaluate the accuracy of the ChatGPT-3.5 and ChatGPT-4 models in addressing queries related to CRRT alarm troubleshooting. This study consisted of two rounds of ChatGPT-3.5 and ChatGPT-4 responses to address 50 CRRT machine alarm questions that were carefully selected by two nephrologists in intensive care...
February 22, 2024: Journal of Personalized Medicine
https://read.qxmd.com/read/38540270/transforming-diabetes-care-the-molecular-pathways-through-which-glp1-ras-impact-the-kidneys-in-diabetic-kidney-disease
#38
REVIEW
Merita Rroji, Goce Spasovski
Diabetic kidney disease (DKD) is a substantial complication of type 2 diabetes (T2D), presenting challenges in chronic kidney disease (CKD) management. In addition to traditional and recent therapies, including angiotensin, converting enzyme (ACE) inhibitors, angiotensin receptor blockers, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and mineralocorticoid receptor antagonists, the evolution of antihyperglycemic treatments has introduced a promising agent, glucagon-like peptide-1 receptor agonist (GLP-1RA) for the management of DKD...
March 14, 2024: Biomedicines
https://read.qxmd.com/read/38538076/benchmarking-digital-displays-monitors-for-histological-diagnoses-the-nephropathology-use-case
#39
JOURNAL ARTICLE
Giorgio Cazzaniga, Francesco Mascadri, Stefano Marletta, Alessandro Caputo, Gabriele Guidi, Giovanni Gambaro, Albino Eccher, Angelo Paolo Dei Tos, Fabio Pagni, Vincenzo L'Imperio
AIM: The digital transformation of the pathology laboratory is being continuously sustained by the introduction of innovative technologies promoting whole slide image (WSI)-based primary diagnosis. Here, we proposed a real-life benchmark of a pathology-dedicated medical monitor for the primary diagnosis of renal biopsies, evaluating the concordance between the 'traditional' microscope and commercial monitors using WSI from different scanners. METHODS: The College of American Pathologists WSI validation guidelines were used on 60 consecutive renal biopsies from three scanners (Aperio, 3DHISTECH and Hamamatsu) using pathology-dedicated medical grade (MG), professional grade (PG) and consumer-off-the-shelf (COTS) monitors, comparing results with the microscope diagnosis after a 2-week washout period...
March 27, 2024: Journal of Clinical Pathology
https://read.qxmd.com/read/38538017/obesity-and-extracorporeal-membrane-oxygenation
#40
REVIEW
Dana E Coccola, Kenneth E Remy, Ira M Cheifetz
Obesity is increasing in prevalence worldwide and carries a theoretical increased risk of morbidity and mortality in critical illness, including hypercoagulability, thrombosis, and renal dysfunction. Obesity has historically been considered a relative contraindication to candidacy for extracorporeal membrane oxygenation (ECMO); however, recent research has suggested that obesity may be associated with improved outcomes in ECMO. This review was conducted to assess and synthesize the existing literature on ECMO outcomes in the obese population...
March 27, 2024: Respiratory Care
keyword
keyword
13171
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.